BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22958491)

  • 1. TGF-β/BMP pathways and the podocyte.
    Tossidou I; Schiffer M
    Semin Nephrol; 2012 Jul; 32(4):368-76. PubMed ID: 22958491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-binding protein-3 modulates TGF-beta/BMP-signaling in glomerular podocytes.
    Peters I; Tossidou I; Achenbach J; Woroniecki R; Mengel M; Park JK; Paschy M; de Groot K; Haller H; Schiffer M
    J Am Soc Nephrol; 2006 Jun; 17(6):1644-56. PubMed ID: 16672319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the TGF-β/BMP-7/Smad pathways in renal diseases.
    Meng XM; Chung AC; Lan HY
    Clin Sci (Lond); 2013 Feb; 124(4):243-54. PubMed ID: 23126427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gremlin aggravates hyperglycemia-induced podocyte injury by a TGFβ/smad dependent signaling pathway.
    Li G; Li Y; Liu S; Shi Y; Chi Y; Liu G; Shan T
    J Cell Biochem; 2013 Sep; 114(9):2101-13. PubMed ID: 23553804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.
    Zeisberg M; Hanai J; Sugimoto H; Mammoto T; Charytan D; Strutz F; Kalluri R
    Nat Med; 2003 Jul; 9(7):964-8. PubMed ID: 12808448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of TGF-beta on podocyte growth and disease progression in proliferative podocytopathies.
    Lee HS; Song CY
    Kidney Blood Press Res; 2010; 33(1):24-9. PubMed ID: 20185928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocyte injury is suppressed by 1,25-dihydroxyvitamin D via modulation of transforming growth factor-beta 1/bone morphogenetic protein-7 signalling in puromycin aminonucleoside nephropathy rats.
    Xiao HQ; Shi W; Liu SX; Zhang B; Xu LX; Liang XL; Liang YZ
    Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):682-9. PubMed ID: 19594554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-beta concentration specifies differential signaling profiles of growth arrest/differentiation and apoptosis in podocytes.
    Wu DT; Bitzer M; Ju W; Mundel P; Böttinger EP
    J Am Soc Nephrol; 2005 Nov; 16(11):3211-21. PubMed ID: 16207831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of mitochondrial Nox4 mediates TGF-β-induced apoptosis in cultured mouse podocytes.
    Das R; Xu S; Quan X; Nguyen TT; Kong ID; Chung CH; Lee EY; Cha SK; Park KS
    Am J Physiol Renal Physiol; 2014 Jan; 306(2):F155-67. PubMed ID: 24259511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury.
    Mitu GM; Wang S; Hirschberg R
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1641-8. PubMed ID: 17804487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A road map toward defining the role of Smad signaling in hematopoietic stem cells.
    Utsugisawa T; Moody JL; Aspling M; Nilsson E; Carlsson L; Karlsson S
    Stem Cells; 2006 Apr; 24(4):1128-36. PubMed ID: 16357343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMP-7 attenuates TGF-β1-induced fibroblast-like differentiation of rat dermal papilla cells.
    Bin S; Li HD; Xu YB; Qi SH; Li TZ; Liu XS; Tang JM; Xie JL
    Wound Repair Regen; 2013; 21(2):275-81. PubMed ID: 23437931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BMP-7 attenuated silica-induced pulmonary fibrosis through modulation of the balance between TGF-β/Smad and BMP-7/Smad signaling pathway.
    Liang D; Wang Y; Zhu Z; Yang G; An G; Li X; Niu P; Chen L; Tian L
    Chem Biol Interact; 2016 Jan; 243():72-81. PubMed ID: 26585589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone morphogenetic protein-7 inhibits silica-induced pulmonary fibrosis in rats.
    Yang G; Zhu Z; Wang Y; Gao A; Niu P; Tian L
    Toxicol Lett; 2013 Jul; 220(2):103-8. PubMed ID: 23639248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperation of H2O2-mediated ERK activation with Smad pathway in TGF-beta1 induction of p21WAF1/Cip1.
    Kim YK; Bae GU; Kang JK; Park JW; Lee EK; Lee HY; Choi WS; Lee HW; Han JW
    Cell Signal; 2006 Feb; 18(2):236-43. PubMed ID: 15979845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification.
    Sakou T; Onishi T; Yamamoto T; Nagamine T; Sampath Tk; Ten Dijke P
    J Bone Miner Res; 1999 Jul; 14(7):1145-52. PubMed ID: 10404014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling cross-talk between IGF-binding protein-3 and transforming growth factor-(beta) in mesenchymal chondroprogenitor cell growth.
    O'Rear L; Longobardi L; Torello M; Law BK; Moses HL; Chiarelli F; Spagnoli A
    J Mol Endocrinol; 2005 Jun; 34(3):723-37. PubMed ID: 15956343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of activator protein 1 transcriptional activity in the regulation of gene expression by transforming growth factor beta1 and bone morphogenetic protein 2 in ROS 17/2.8 osteoblast-like cells.
    Palcy S; Bolivar I; Goltzman D
    J Bone Miner Res; 2000 Dec; 15(12):2352-61. PubMed ID: 11127200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cyclin-dependent kinase inhibitor p21 is required for TGF-beta1-induced podocyte apoptosis.
    Wada T; Pippin JW; Terada Y; Shankland SJ
    Kidney Int; 2005 Oct; 68(4):1618-29. PubMed ID: 16164639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells.
    Maeda S; Hayashi M; Komiya S; Imamura T; Miyazono K
    EMBO J; 2004 Feb; 23(3):552-63. PubMed ID: 14749725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.